Gurnet Point Capital, a private equity and venture capital firm, and Patient Square Capital, a health care investment firm, completed the acquisition of Radius Health, a biopharmaceutical company, for $890m. “We are delighted to be acquiring Radius and providing additional resources to the Company during this critical time. We fully believe in the value of the Company’s portfolio and are looking forward to working closely with the Company to deliver a positive impact for patients,” Travis Wilson, Gurnet Point Partner.